Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 93 of 114

  1. TKI

    United Therapeutics Europe Ltd

    NSCLC

    phase 3 small molecule active

    1 trial

  2. TLX-101-Tx + Lomustine

    Telix Innovations

    Neoplastic Disease

    phase 3 other active

    1 trial

  3. TMC125

    Elan Pharma International

    HIV-1

    phase 3 small molecule completed

    1 trial

  4. TNK-tPA

    The First People's Hospital of Lianyungang

    Acute Ischemic Stroke

    phase 3 small molecule active

    1 trial

  5. TNX-102 SL

    Tonix Pharmaceuticals Holding

    PTSD

    phase 3 small molecule terminated

    6 trials

  6. TNX-102 SL

    Tonix Pharmaceuticals Holding

    Fibromyalgia

    phase 3 small molecule completed

    2 trials

  7. TNX-102 SL

    Tonix Pharmaceuticals Holding

    Primary Fibromyalgia

    phase 3 small molecule completed

    1 trial

  8. TNX-102 SL 2.8mg

    Tonix Pharmaceuticals Holding

    Primary Fibromyalgia

    phase 3 small molecule completed

    1 trial

  9. TNX-102 SL 5.6 mg

    Tonix Pharmaceuticals Holding

    PTSD

    phase 3 small molecule completed

    1 trial

  10. TNX-102 SL Tablet 2.8 mg

    Tonix Pharmaceuticals Holding

    Primary Fibromyalgia

    phase 3 small molecule completed

    1 trial

  11. TNX-102 SL Tablet, 2.8 mg

    Tonix Pharmaceuticals Holding

    Fibromyalgia

    phase 3 small molecule terminated

    1 trial

  12. TNX-102 SL Tablet, 2.8mg

    Tonix Pharmaceuticals Holding

    Fibromyalgia

    phase 3 small molecule completed

    1 trial

  13. TNX-102 SL Tablet, 5.6 mg

    Tonix Pharmaceuticals Holding

    Fibromyalgia

    phase 3 small molecule completed

    1 trial

  14. TNX-103

    TENAX THERAPEUTICS, INC.

    Pulmonary Hypertension Associated With HFpEF

    phase 3 small molecule active

    2 trials

  15. TNX-103

    TENAX THERAPEUTICS, INC.

    Pulmonary Hypertension

    phase 3 small molecule active

    1 trial

  16. TNX-103-07

    TENAX THERAPEUTICS, INC.

    Pulmonary Hypertension (PH) with Heart Failure with preserved left ventricular ejection fraction (PH-HFpEF)

    phase 3 small molecule active

    1 trial

  17. TOCILIZUMAB, Placebo of Tocilizumab

    Pari Pharma GmbH

    Giant cell arteritis with Cerebro-vascular involvement

    phase 3 small molecule active

    1 trial

  18. TP-03

    Tarsus Pharmaceuticals

    Blepharitis

    phase 3 small molecule completed

    1 trial

  19. TP-03, 0.25%

    Tarsus Pharmaceuticals

    Blepharitis

    phase 3 small molecule completed

    1 trial

  20. TPO

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    phase 3 small molecule active

    1 trial

  21. TPOXX

    United Therapeutics Europe Ltd

    Smallpox

    phase 3 small molecule completed

    1 trial

  22. TPST-1120

    Tempest Therapeutics

    Hepatocellular Carcinoma (HCC)

    phase 3 small molecule active

    1 trial

  23. TQJ230

    Novartis Pharmaceuticals

    Atherosclerotic cardiovascular disease (ASCVD)

    phase 3 small molecule active

    1 trial

  24. TRACK_001

    The George Institute

    Improvement of cardiovascular outcomes in patients with advanced chronic kidney disease. In easily understood language, this is Heart and blood vessel disease and Kidney disease.

    phase 3 small molecule active

    1 trial

  25. TREPaed

    AOP Orphan Pharmaceuticals GmbH

    Pulmonary Arterial Hypertension (PAH)

    phase 3 small molecule active

    1 trial

  26. TRIGON DEPOT 40 mg/ml suspensión inyectable.

    The George Institute

    Chronic shoulder pain

    phase 3 small molecule active

    1 trial

  27. TRIO041

    Wuhan Createrna Science and Technology Co., Ltd

    Intermediate-stage hepatocellular carcinoma with beyond up-to-7 criteria.

    phase 3 small molecule active

    1 trial

  28. TROMALYT 150 mg cápsulas duras de liberación prolongada

    The George Institute

    Women infertility

    phase 3 small molecule active

    1 trial

  29. TV-1106

    Teva Pharma GmbH

    Growth Hormone-Deficiency

    phase 3 small molecule terminated

    4 trials

  30. TV-44749

    Teva Pharma GmbH

    Schizophrenia

    phase 3 small molecule completed

    3 trials

  31. TV-46000

    Teva Pharma GmbH

    Schizophrenia

    phase 3 small molecule completed

    2 trials

  32. TV-46763

    Teva Pharma GmbH

    Pain

    phase 3 small molecule completed

    1 trial

  33. TV48125-CNS-30084

    Lacuna Pharma Pty Ltd

    Episodic and Chronic Migraine

    phase 3 small molecule active

    1 trial

  34. TVB-009

    Teva Pharma GmbH

    Osteoporosis, Postmenopausal

    phase 3 other completed

    1 trial

  35. TVP-1012

    Takeda

    Parkinson's Disease

    phase 3 small molecule completed

    1 trial

  36. TVP-1012 1mg

    Takeda

    Parkinson's Disease

    phase 3 small molecule completed

    3 trials

  37. TVTX-TVT058-301

    Travere Therapeutics

    Classical Homocystinuria

    phase 3 small molecule active

    1 trial

  38. TX200-TR101

    SANGAMO THERAPEUTICS, INC

    Kidney Transplant Rejection

    phase 3 small molecule active

    1 trial

  39. TachoSil®

    Takeda

    Hemorrhage

    phase 3 mab completed

    1 trial

  40. TachoSil®

    Takeda

    Bleeding

    phase 3 small molecule completed

    1 trial

  41. TachoSil®

    Takeda

    Cerebrospinal Fluid Leaks

    phase 3 other completed

    1 trial

  42. Tacrolimus

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Transplantation

    phase 3 small molecule active

    1 trial

  43. Tacrolimus

    Hospital Authority, Hong Kong

    Graft vs Host Disease

    phase 3 small molecule completed

    1 trial

  44. Tacrolimus

    Takeda

    Ulcerative Colitis

    phase 3 small molecule terminated

    1 trial

  45. Tacrolimus BID

    Teva Pharma GmbH

    Medication Adherence

    phase 3 small molecule active

    1 trial

  46. Tacrolimus capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Myasthenia Gravis

    phase 3 small molecule completed

    1 trial

  47. Tacrolimus capsule

    Astellas Pharma Inc

    Myasthenia Gravis

    phase 3 small molecule completed

    1 trial

  48. Tacrolimus capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lupus Nephritis

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.